Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-07-27 Trucksis Michele Chief Medical Officer and EVP Exercise or conversion +38,064 $15.77 $600K 38,064
2016-07-27 Trucksis Michele Chief Medical Officer and EVP Sale −38,064 $35.14 $1.3M 0
2016-07-27 Trucksis Michele Chief Medical Officer and EVP Exercise or conversion · Stock Option (Right to Buy) +38,064 301,060
2016-07-25 Aunins John G. Chief Technology Officer & EVP Sale −9,390 $34.18 $321K 210,765
2016-07-22 Aunins John G. Chief Technology Officer & EVP Exercise or conversion +187,500 $0.48 $90K 220,155
2016-07-22 Aunins John G. Chief Technology Officer & EVP Exercise or conversion · Stock Option (right to buy) −187,500 12,500
2016-07-06 Pomerantz Roger President and CEO Exercise or conversion +35,435 $0.71 $25K 219,127
2016-07-06 Pomerantz Roger President and CEO Sale −9,900 $29.27 $290K 209,227
2016-07-06 Pomerantz Roger President and CEO Sale −25,535 $29.80 $761K 183,692
2016-07-06 Pomerantz Roger President and CEO Exercise or conversion · Stock Option (right to buy) −35,435 1,072,283
2016-07-05 Pomerantz Roger President and CEO Exercise or conversion +52,776 $0.71 $37K 236,468
2016-07-05 Pomerantz Roger President and CEO Sale −49,871 $29.27 $1.5M 186,597
2016-07-05 Pomerantz Roger President and CEO Sale −2,905 $29.96 $87K 183,692
2016-07-05 Pomerantz Roger President and CEO Exercise or conversion · Stock Option (right to buy) −52,776 1,107,718
2016-07-01 Pomerantz Roger President and CEO Exercise or conversion +56,789 $0.71 $40K 240,481
2016-07-01 Pomerantz Roger President and CEO Sale −4,832 $29.12 $141K 235,649
2016-07-01 Pomerantz Roger President and CEO Sale −41,957 $29.84 $1.3M 193,692
2016-07-01 Pomerantz Roger President and CEO Sale −10,000 $30.00 $300K 183,692
2016-07-01 Pomerantz Roger President and CEO Exercise or conversion · Stock Option (right to buy) −56,789 1,160,497
2016-06-30 Shaff Eric D. CFO and EVP Exercise or conversion +4,533 $7.79 $35K 4,533

Page 32 of 34 · 662 trades